Riversedge Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$884K Buy
6,880
+355
+5% +$41.6K 0.12% 73
2026
Q1
$785K Buy
6,525
+313
+5% +$36.1K 0.13% 63
2025
Q4
$654K Buy
6,212
+373
+6% +$35K 0.11% 64
2025
Q3
$490K Buy
+5,839
New +$481K 0.08% 75
2024
Q4
Sell
-2,077
Closed -$236K 108
2024
Q3
$236K Sell
2,077
-462
-18% -$54.9K 0.05% 81
2024
Q2
$314K Sell
2,539
-78
-3% -$10K 0.08% 69
2024
Q1
$345K Buy
2,617
+133
+5% +$16.4K 0.09% 60
2023
Q4
$271K Buy
+2,484
New +$258K 0.07% 66
2023
Q3
Sell
-1,799
Closed -$208K 73
2023
Q2
$208K Buy
+1,799
New +$204K 0.06% 70
2023
Q1
Sell
-1,866
Closed -$207K 75
2022
Q4
$207K Buy
+1,866
New +$191K 0.07% 65

Other funds holding MRK

Riversedge Advisors's MRK Position: Q2 2026 in Review

Riversedge Advisors increased its Merck (MRK) stake by 5.4% in Q2 2026, buying an estimated $41.6K and bringing the position to 6,880 shares worth $884K. The position accounts for 0.12% of the portfolio, ranked #73.

Riversedge Advisors first reported a position in MRK in Q4 2022 and has held it in 10 quarters since. 1,170 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Riversedge Advisors held 6,880 shares of Merck worth $884K as of Q2 2026.
  • Riversedge Advisors bought 355 Merck shares in Q2 2026, an estimated $41.6K.
  • Merck made up 0.12% of Riversedge Advisors's portfolio in Q2 2026, its #73 holding.
  • Riversedge Advisors first reported a position in Merck in Q4 2022 and has held it in 10 quarters since.
  • 1,170 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Riversedge Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.